Companies: 10,795·Total market cap: $144.5T
Progyny, Inc.

Progyny, Inc.

PGNYNASDAQHealthcare● Active
$26.02
+$0.16(+0.60%)
Market Cap$2.0B
P/E Ratio
52W High$28.75
52W Low$16.1
Overview

Progyny, Inc. (PGNY) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

pgny · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 20 Wall Street analysts in the past 3 months

SellBuy

Buy

20 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
15
Hold
5
Sell
0
Strong Sell
0
Total: 20 · Buy rate: 75.0%

12-Month Price Target

High

$35.00

Consensus

$30.33

+17.3% upside

Low

$27.00

Median: $30 · Last Close: $25.85

The Progyny, Inc. (PGNY) analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month PGNY price target is $30.33, representing +17.3% upside from the current price of $25.85.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $30 (17.3%)

Consensus Target

$30.33

17.3% upside

High Target

$35

35.4%

Low Target

$27

4.4%

Current Price

$25.85

as of today

Based on analyst price targets, the PGNY stock price prediction for the next 12 months ranges from $27 to $35. The consensus PGNY price forecast of $30.33 implies 17.3% upside from the current price of $25.85.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$26.331.87%

1-day model range: $26.1–$26.57. Peak: $26.57 (+1.87%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$32+22.4%
2028$36+38.9%
2029$39+50.2%
2030$41+57.4%
2031+62.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)64.1Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · PGNY · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$25.46BUY
MA 10$25.53BUY
MA 20$24.74BUY
MA 50$20.66BUY
MA 100$20.76BUY
MA 200$21.96BUY
Current $PGNY · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$25.63BUY
EMA 10$25.34BUY
EMA 20$24.33BUY
EMA 50$22.22BUY
EMA 100$21.59BUY
EMA 200$21.72BUY
Current $PGNY · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
B of A Securities2026-06-02
Maintains
BuyBuy
Canaccord Genuity2026-05-19
Upgrade ↑
HoldBuy
Barclays2026-05-18
Maintains
OverweightOverweight
Citizens2026-05-11
Maintains
Market OutperformMarket Outperform
Truist Securities2026-05-11
Maintains
BuyBuy
Barclays2026-03-20
Maintains
OverweightOverweight
Canaccord Genuity2026-03-11
Maintains
HoldHold
BTIG2026-03-05
Maintains
BuyBuy
Keybanc2026-03-02
Maintains
OverweightOverweight
Truist Securities2026-03-02
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Progyny, Inc. (PGNY) stock. Of the recent 97 rating actions, 6 were upgrades and 9 were downgrades. 20 analysts currently cover PGNY.

Analyst Recommendation Trends

Buy ratings11
Hold ratings202
Sell ratings00

PGNY analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.4B

↓ 12.4% YoY

Revenue Next Year

$1.5B

↑ 8.8% YoY

EPS This Year

$1.28

EPS Next Year

$1.48

↑ 15.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PGNY EPS of $1.28 for the current fiscal year, based on estimates from 6 analysts. The PGNY revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PGNY stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PGNY price target is $30.33 (+17.3% upside), with an analyst consensus of Buy.

The PGNY short-term stock prediction for tomorrow is $26.33 (+1.87%). The PGNY stock price prediction for 2027 estimates an average of $32. The PGNY stock prediction for 2030 projects a range of $37–$45.

Progyny, Inc. trades on NASDAQ under the ticker PGNY. The PGNY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PGNY forecast · 8 questions

According to 20 Wall Street analysts, the average 12-month PGNY price target is $30.33, with a high forecast of $35.00 and a low of $27.00. The median price target is shown in the chart above when available. This implies +17.3% potential upside from the current price of $25.85.

PGNY price targetWhat is PGNY price targetPGNY analyst price targetPGNY 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.